Vest Financial LLC grew its position in Genpact Limited (NYSE:G - Free Report) by 48.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,751 shares of the business services provider's stock after purchasing an additional 18,739 shares during the period. Vest Financial LLC's holdings in Genpact were worth $2,480,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. grew its holdings in Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after acquiring an additional 2,060,595 shares during the period. Los Angeles Capital Management LLC purchased a new stake in Genpact in the 3rd quarter worth approximately $19,779,000. Tandem Investment Advisors Inc. purchased a new position in shares of Genpact during the 3rd quarter valued at approximately $17,025,000. Geode Capital Management LLC increased its holdings in shares of Genpact by 12.6% during the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock valued at $148,142,000 after purchasing an additional 413,646 shares in the last quarter. Finally, Franklin Resources Inc. lifted its stake in shares of Genpact by 6.5% in the 3rd quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider's stock valued at $162,318,000 after purchasing an additional 252,674 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.
Genpact Price Performance
Shares of Genpact stock traded up $0.34 during trading hours on Tuesday, reaching $54.78. 2,119,869 shares of the company's stock were exchanged, compared to its average volume of 1,516,021. The business has a fifty day moving average of $45.25 and a two-hundred day moving average of $41.55. The company has a market capitalization of $9.66 billion, a P/E ratio of 19.29, a price-to-earnings-growth ratio of 1.63 and a beta of 1.20. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 1 year low of $30.23 and a 1 year high of $56.76.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.61%. As a group, research analysts predict that Genpact Limited will post 3.08 earnings per share for the current fiscal year.
Genpact Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be issued a $0.17 dividend. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.24%. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio is currently 21.48%.
Analysts Set New Price Targets
G has been the subject of a number of recent analyst reports. Needham & Company LLC lifted their price objective on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $45.00 to $60.00 in a report on Friday. Mizuho boosted their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday. Robert W. Baird increased their target price on Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Finally, Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $48.44.
View Our Latest Report on Genpact
Insider Buying and Selling
In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the sale, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at approximately $11,926,218.40. This trade represents a 4.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 35,058 shares of company stock worth $1,558,675. Insiders own 2.80% of the company's stock.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
![Institutional Ownership by Quarter for Genpact (NYSE:G)](https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&Symbol=G)
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report